diverse psychotomimetics act common signaling pathway 
three distinct classes drugs: dopaminergic agonists d-amphetamine serotonergic agonists lsd glutamatergic antagonists pcp induce psychotomimetic states experimental animals closely resemble schizophrenia symptoms humans implicate common signaling pathway mediating effects pathway dopamine adenosine -monophosphate camp-regulated phosphoprotein kilodaltons darpp- phosphorylated dephosphorylated three sites pattern predicted cause synergistic inhibition protein phosphatase concomitant regulation downstream effector proteins glycogen synthesis kinase gsk- camp response element-binding protein creb c-fos mice genetic deletion darpp point mutations phosphorylation sites darpp- effects d-amphetamine lsd pcp two behavioral parameters-sensorimotor gating repetitive movements-were strongly attenuated 
